Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Confused about the difference between GLP-1 and GIP for weight loss? Learn how these hormones work, compare medications like Wegovy®, Ozempic®, and Mounjaro®, and discover which medical weight loss treatment may be suitable for your health goals.